Ebola virus: from discovery to vaccine
- 1 August 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 3 (8), 677-685
- https://doi.org/10.1038/nri1154
Abstract
Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre- and post-exposure interventions makes the development of rapid diagnostics, new antiviral agents and protective vaccines a priority for many nations. Further insight into the ecology, immunology and pathogenesis of Ebola virus will promote the delivery of these urgently required tools.Keywords
This publication has 71 references indexed in Scilit:
- Catastrophic ape decline in western equatorial AfricaNature, 2003
- Hemorrhagic Fever Viruses as Biological WeaponsJAMA, 2002
- Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell CultureJournal of Virology, 2002
- Recovery of Infectious Ebola Virus from Complementary DNA: RNA Editing of the GP Gene and Viral CytotoxicityScience, 2001
- Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injuryNature Medicine, 2000
- Isolation and partial characterisation of a new strain of Ebola virusThe Lancet, 1995
- Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United StatesJournal of Comparative Pathology, 1992
- Preliminary report: isolation of Ebola virus from monkeys imported to USAThe Lancet, 1990
- Ultrastructural pathology of experimental ebola haemorrhagic fever virus infectionThe Journal of Pathology, 1985
- Zur Ätiologie einer unbekannten, von Affen ausgegangenen menschlichen InfektionskrankheitDeutsche Medizinische Wochenschrift (1946), 1967